학술논문
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study
Document Type
Article
Author
Cai, C.X.; Tran, D.; Nishimura, A.; Westlund, E.; Zeger, S.L.; Bowring, M.G.; Ng, J.H.; Nagy, P.; Cook, M.; McLeggon, J.-A.; Falconer, T.; Zhang, L.; Hripcsak, G.; DuVall, S.L.; Suchard, M.A.; Matheny, M.E.; Golozar, A.; Ostropolets, A.; Lawrence-Archer, L.; Minty, E.; Desai, P.; Bu, F.; Toy, B.; Lee, E.; Gilbert, Z.; Hribar, M.; Goetz, K.; Boland, M.V.; Hall, N.; Shoaibi, A.; Reps, J.; Sena, A.G.; Blacketer, C.; Swerdel, J.; Ryan, P.B.; Jhaveri, K.D.; Crews, D.C.
Source
In: Ophthalmology Retina . (Ophthalmology Retina, August 2024, 8(8):733-743)
Subject
Language
English
ISSN
24686530